The role of tumor necrosis factor (TNF) in macrophage-dependent neutrophil accumulation induced by lipopolysaccharide (LPS) was examined through the use of cutaneous air pouches formed on the backs of mice. To investigate the possibility that TNF functions in LPS-induced neutrophil accumulation, we inJected LPS into newly formed air pouches (containing relatively few endogenous macrophages), 48-h-old air pouches (containing large numbers of endogenous macrophages), or newly formed air pouches instilled with 106 alveolar macrophages (AM). Six hours after LPS injection, air pouches possessing either AM or endogenous macrophages contained large numbers of neutrophils. Infusion of anti-TNF immunoglobulin G into the air pouches inhibited LPS-induced neutrophil accumulation by 84% in air pouches containing AM and 71% in air pouches containing large numbers of endogenous macrophages. TNF was also capable of including neutrophil accumulation when injected into air pouches containing relatively large numbers of either endogenous or exogenous macrophages but not when injected into air pouches containing small numbers of macrophages. In addition, incubation of AM in vitro with TNF induced the AM to cause neutrophil accumulation upon inection into newly formed air pouches. These results indicate that TNF functions in LPS-induced neutrophil accumulation. Furthermore, the results indicate that TNF functions by enhancing the ability of macrophages to cause neutrophil emigration. This is consistent with the possibility that LPS induces TNF production and that TNF, in turn, induces macrophages to produce cytokines with inflammatory activities.
The role of tumor necrosis factor (TNF) in macrophage-dependent neutrophil accumulation induced by lipopolysaccharide (LPS) was examined through the use of cutaneous air pouches formed on the backs of mice. To investigate the possibility that TNF functions in LPS-induced neutrophil accumulation, we inJected LPS into newly formed air pouches (containing relatively few endogenous macrophages), 48-h-old air pouches (containing large numbers of endogenous macrophages), or newly formed air pouches instilled with 106 alveolar macrophages (AM). Six hours after LPS injection, air pouches possessing either AM or endogenous macrophages contained large numbers of neutrophils. Infusion of anti-TNF immunoglobulin G into the air pouches inhibited LPS-induced neutrophil accumulation by 84% in air pouches containing AM and 71% in air pouches containing large numbers of endogenous macrophages. TNF was also capable of including neutrophil accumulation when injected into air pouches containing relatively large numbers of either endogenous or exogenous macrophages but not when injected into air pouches containing small numbers of macrophages. In addition, incubation of AM in vitro with TNF induced the AM to cause neutrophil accumulation upon inection into newly formed air pouches. These results indicate that TNF functions in LPS-induced neutrophil accumulation. Furthermore, the results indicate that TNF functions by enhancing the ability of macrophages to cause neutrophil emigration. This is consistent with the possibility that LPS induces TNF production and that TNF, in turn, induces macrophages to produce cytokines with inflammatory activities.
Invasion of host tissue by gram-negative bacteria induces a vigorous inflammatory response characterized by neutrophil accumulation. This response is thought to be important in resistance to infection by gram-negative bacteria (17, 18) . Comparative studies of lipopolysaccharide (LPS)-responder and nonresponder mice suggest that neutrophil accumulation that occurs at sites of gram-negative bacterial infections is dependent on an LPS-induced host response (17, 24) . However, although LPS-induced neutrophil accumulation is important in defense against infection by gram-negative bacteria, the mechanisms by which LPS causes neutrophils to accumulate at sites of infection is not established.
Evidence was presented in a recent report from this laboratory showing that LPS-induced neutrophil accumulation in the lungs is dependent on the function of alveolar macrophages (AM) (8) . It was considered likely, therefore, that AM function in LPS-induced neutrophil accumulation through the production of inflammatory monokines. Indeed, LPS is known to cause the production of tumor necrosis factor (TNF) by macrophages, and it has been suggested that TNF plays a role in neutrophil accumulation (2) . However, whether TNF does play a role in LPS-induced neutrophil accumulation remains controversial. For example, Cybulsky et al. (4) reported that TNF is not a potential mediator of LPS-induced neutrophil accumulation. However, several other laboratories (15, 23) being directly chemotactic for neutrophils (14) . It is also possible that TNF has an autocrine function in neutrophil accumulation (16) . TNF has been shown to be capable of enhancing the production by macrophages of a number of inflammatory cytokines such as IL-1 (5), macrophage inflammatory protein (25) , monocyte-derived neutrophil chemotactic factor (13) , platelet-activating factor (21) , and TNF itself (11 cells in 100,ul of Eagle minimal essential medium (Microbiological Associates, Walkersville, Md.) containing 5% fetal bovine serum and antibiotics were placed in individual wells of 96-well (flat-bottomed) microdilution plates and incubated overnight at 37°C in a humidified 5% C02 atmosphere. Sequential twofold dilutions of the test preparations were made in the above-described medium containing 2 ,ug of actinomycin D (Calbiochem-Behring, La Jolla, Calif.) per ml, and 100 ,ul of each dilution was added to replicate wells of L929B-preseeded microdilution plates. After 24 h of incubation, cytotoxicity was scored microscopically. The cytotoxicity titer (units per milliliter) was defined as the highest dilution of test sample that caused the destruction of 50% or more actinomycin D-treated L929B cells.
Lung lavage. To obtain AM for cell transfer studies, we lavaged the lungs of mice by a procedure similar to that described previously (8) . Mice were anesthetized with halothane gas and exsanguinated. The trachea was exposed and intubated, and the lungs were lavaged with 10 1-ml volumes of Hanks balanced salt solution (HBSS) without Ca2' and Mg2+ (GIBCO Laboratories, Grand Island, N.Y.) but containing 3 mM EDTA (HBSS-EDTA). The cells were washed three times in HBSS, counted, and suspended to 1.0 x 107 cells per ml of HBSS. The HBSS used in these experiments contained less than 0.02 ng of LPS per ml, as determined with the E-toxate kit (Sigma). Typically, at least 95% of the recovered cells were AM, the rest being neutrophils, lymphocytes, and epithelial cells. Differential cell counts were obtained by light microscopy of cell smears produced by use of a cytocentrifuge (Shandon, Pittsburgh, Pa.) and stained with Diff-Quik (American Scientific Products, McGaw Park, Ill.).
Injection of air pouches. Air pouches were produced on the dorsal cervical region of mice by subcutaneous injection of 0.4 ml of air (8, 19) . Suspensions of 106 AM, soluble factors (LPS, rTNF, or anti-rTNF IgG), or AM plus soluble factors were immediately injected into the air pouches. After 6 h, the mice were killed by C02 inhalation, and a 20-g needle was inserted into the lumen of the air pouch. Placement of the needle end in the lumen of the air pouch was confirmed by the aspiration of air from the air pouch. The air pouch was lavaged by injection of 2 ml of HBSS-EDTA and subsequent aspiration of the fluid. Total numbers of cells in lavage fluids were determined with a hemacytometer. Differential cell counts were obtained from cell smears stained with DiffQuik.
Statistics. The statistical significance of differences in mean numbers of neutrophils in lavage fluids of various AM were included in the suspensions injected into the air pouches because it was previously determined that LPSinduced neutrophil accumulation in a newly formed air pouch is greatly enhanced by the presence of AM (8) . After 6 h, the mice were killed, their air pouches were lavaged, and neutrophil numbers in the lavage fluids were determined.
Few neutrophils were found in the lavage fluids of air pouches infused with AM only (Fig. 1) . The lavage fluids of air pouches infused with LPS, AM, and control IgG contained about 5.8 x 106 neutrophils per ml. However, the lavage fluids of air pouches infused with AM, LPS, and antibodies to rTNF had only about 9.0 x 105 neutrophils per ml. This represents a significant reduction in LPS-induced neutrophil accumulation (P < 0.02).
In other experiments, the effect of anti-rTNF IgG on endogenous macrophage-dependent neutrophil accumulation induced by LPS was investigated. Air pouches were made on the dorsa of mice as before. After 48 h, the air Neutrophil numbers in the lavage fluids of the air pouches were determined after 6 h. Few neutrophils were found in the lavage fluids of air pouches that had been infused with HBSS only (Fig. 2) . The lavage fluids of air pouches infused with LPS and control IgG contained about 2.3 x 106 neutrophils per ml. However, the lavage fluids from air pouches infused with LPS and anti-rTNF IgG had only about 6.5 x 105 neutrophils per ml. This represents a significant reduction in neutrophil accumulation (P < 0.05) as a result of treatment with antibodies to rTNF.
AM were not injected into the 48-h-old air pouches because it is known that by 48 h, air pouches possess significant numbers of endogenous macrophages (19) . However, to confirm this, we enumerated macrophages and neutrophils in lavage fluids of untreated newly formed air pouches and untreated 48-h-old air pouches. The numbers of macrophages and neutrophils in lavage fluids from newly made air pouches were at or below the limits of detection (<3 x 103). (Fig. 3) . Similarly, 48-h-old air pouches that received injections of 1 x 104 or 1 x 105 units of rTNF also contained significant numbers of neutrophils, in comparison with air pouches that received injections of vehicle only. However, the neutrophil numbers were significantly higher in the 48-h-old air pouches than in the newly formed air pouches at both 1 x 104 and 1 x 105 units of rTNF.
To further investigate possible interactions between exogenous rTNF and macrophages, we infused newly formed air pouches with HBSS (0.1 ml), 106 AM, 5 x 103 units of rTNF, or 106 AM and 5 x 103 units of rTNF, all in 0.1 ml of HBSS. After 6 h, the mice were killed, their air pouches were lavaged, and the numbers of neutrophils in the lavage fluids were determined. When injected alone, neither AM nor rTNF caused a significant increase in neutrophil accumulation in air pouches (Fig. 4) . However, when AM and rTNF were injected together, large numbers of neutrophils were found in the air pouch lavage fluids. In a different experiment, AM were collected from mice that had been given an intratracheal instillation of 107 viable Mycobacterium bovis BCG 4 6 . Numbers of neutrophils in lavage fluids of newly formed air pouches 6 h after injection with vehicle or with 106 AM that had been incubated in vitro with no rTNF, 104 units (u) of rTNF per ml, or 105 units of rTNF per ml. Bars represent means ± 1 SD for four mice. *, Significantly greater than the value for air pouches injected with AM incubated without rTNF (P < 0.02). neutrophils per ml (Fig. 6) . However, lavage fluids from air pouches injected with AM preincubated with either 104 or 105 units of rTNF per ml had significantly more (P < 0.02) neutrophils per milliliter (about 6.5 x 105 and 7.5 x 105, respectively) than did lavage fluids from air pouches injected with AM preincubated without rTNF. DISCUSSION Anti-rTNF IgG was found to inhibit by 84% AM-dependent LPS-induced neutrophil accumulation in cutaneous air pouches. Similarly, when anti-rTNF IgG was injected into 48-h-old air pouches, LPS-induced neutrophil accumulation was inhibited by 71%. These results provide causal evidence that TNF plays an important role in neutrophil accumulation at sites of LPS deposition and also confirms the results of Movat et al. (15) that suggest that TNF functions as a mediator of LPS-induced neutrophil accumulation.
It is of interest that the anti-rTNF treatment reduced but did not completely inhibit neutrophil accumulation. This may mean that the anti-rTNF treatment did not neutralize all endogenous TNF produced in response to LPS injection. This seems unlikely, however, because we injected 5 x 105 NU of anti-rTNF IgG directly into the air pouches. This is a dose shown previously to be effective systemically in blocking a TNF-mediated mechanism required for resistance against Listeria monocytogenes (9) . We also found that higher doses of anti-rTNF IgG did not result in a greater inhibitory effect on neutrophil accumulation (results not shown). It is also possible that TNF produced in the air pouches bound to target cells in close proximity before anti-rTNF IgG could neutralize it. Alternatively, it is possible that TNF produced in the air pouches was completely neutralized by anti-rTNF IgG, yet some neutrophil emigration still occurred. This result would be consistent with the possibility that TNF enhances neutrophil emigration but is not obligatory for neutrophil accumulation to occur.
The finding that the injection of either rTNF or AM alone did not cause neutrophils to accumulate in air pouches, whereas rTNF and AM injected together caused large num- bers of neutrophils to accumulate, suggests that the in vivo inflammatory activity of TNF is dependent on the presence of macrophages. Further evidence in keeping with this contention is that rTNF did not cause neutrophil accumulation in newly formed air pouches, which contained relatively few macrophages, but caused substantial accumulation in 48-h-old air pouches, which contained many more macrophages.
The finding that incubation of AM with rTNF in vitro enhanced the ability of AM to cause neutrophil accumulation upon injection into air pouches suggests that TNF can cause neutrophil accumulation through direct effects on macrophages. Macrophages have receptors for TNF (10) , and TNF has been shown to induce Ia expression (3), cytotoxicity (16) , and mycobactericidal mechanisms (1) in macrophages. It is known, moreover, that TNF can enhance the production by macrophages of other mediators of inflammation, such as monocyte-derived neutrophil chemotactic factor (13), macrophage inflammatory protein (25) , platelet-activating factor (21) , and IL-1 (5). Therefore, it is possible that macrophage-produced TNF has an autocrine function in LPS-induced inflammation by inducing macrophages to produce additional inflammatory mediators. Kindler et al. (11) found that treatment of BCG-infected mice with rabbit anti-TNF serum suppressed granuloma formation and mycobacterial elimination from livers of the hosts. They also found that anti-TNF treatment suppressed the accumulation of TNF mRNA and protein. These results led them to hypothesize that TNF release from macrophages is involved in a process of autoamplification, such as in an autocrine or paracrine manner. If TNF does mediate macrophage function in inflammation by an autocrine mechanism, it might explain our inability to totally ablate neutrophil emigration with anti-rTNF IgG. It is possible, for example, that neutralizing TNF in vivo with anti-rTNF IgG inhibited TNFdependent enhancement of inflammatory cytokine production by macrophages but did not suppress inflammatory cytokine production that had been triggered directly by LPS.
In any case, the results presented suggest that TNF can function in inflammation through direct effects on macrophages. However, the results do not rule out the possibility that TNF has effects on neutrophil emigration that are independent of direct effects on macrophages. TNF has been shown to increase the adhesiveness of endothelium for neutrophils (7) and is chemotactic for neutrophils (14) . Thus, it is possible that TNF functions in inflammation by having direct effects on endothelial cells or neutrophils, but only in the presence of additional stimuli such as other cytokines produced by macrophages. It has been shown, for example, that some activities of TNF are greatly enhanced by IL-1 (12, 15, 23) . Thus, it is also possible that macrophages are required in LPS-induced neutrophil accumulation to supply mediators which then act synergistically with TNF on target cells other than macrophages.
The possibility that TNF must act synergistically with other cytokines to cause neutrophil accumulation could explain the apparent differences between results of the present investigation and those recently described by Cybulsky et al. (4) . They concluded that IL-1 but not TNF was a potential mediator of LPS-induced neutrophil emigration. This conclusion was based on their ability to demonstrate tachyphylaxis between IL-1 and LPS but not between TNF and IL-1 or between TNF and LPS. However, if TNF does indeed affect neutrophil emigration by acting synergistically with other cytokines, it might be expected that TNF does not induce tachyphylaxis when injected by itself. It is also possible that species differences could explain the disparity between our results and those of Cybulsky et al. (4) . They utilized human TNF in a rabbit model of cutaneous neutrophil emigration, whereas we utilized mouse rTNF in a mouse cutaneous air pouch model. In this regard, it would be interesting to determine whether the inhibition of IL-1 activity in the mouse air pouch model inhibits neutrophil accumulation. However, we have not yet found a potent antibody to mouse IL-1 that efficiently neutralizes IL-1 in vivo.
In summary, the results of this investigation indicate that TNF can play a role in the accumulation of neutrophils in air pouches in response to LPS deposition. However, whether TNF is obligatory for neutrophil emigration is not known. The results also show that the inflammation-inducing activity of TNF is dependent on the presence of macrophages and that TNF augments neutrophil accumulation through direct effects on macrophages.
